Silo Pharma, Inc. (SILO) SEC Filings & Financial Intelligence
Silo Pharma, Inc. (SILO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SILO
CIK: 1514183
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Salberg & Company, P.A.
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerRyan Barth
Audit LocationBoca Raton, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-14 | 2026-10-13 | CURRENT REPORT | 0001213900-26-109457 | View SEC Doc Filr Page |
| 8-K | 2026-10-02 | 2026-10-01 | CURRENT REPORT | 0001213900-26-106435 | View SEC Doc Filr Page |
| 8-K | 2026-08-19 | 2026-08-18 | CURRENT REPORT | 0001213900-26-091783 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-14 | CURRENT REPORT | 0001213900-26-090748 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-089085 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001213900-26-088836 | View SEC Doc Filr Page |
| EFFECT | 2026-08-06 | — | EFFECT Filing | 9999999995-26-002570 | View SEC Doc Filr Page |
| 424B3 | 2026-08-06 | — | PROSPECTUS | 0001213900-26-086219 | View SEC Doc Filr Page |
| S-8 | 2026-07-31 | — | REGISTRATION STATEMENT | 0001213900-26-083957 | View SEC Doc Filr Page |
| S-3 | 2026-07-24 | — | REGISTRATION STATEMENT | 0001213900-26-081368 | View SEC Doc Filr Page |
| D | 2026-07-14 | — | D Filing | 0001213900-26-077974 | View SEC Doc Filr Page |
| 8-K | 2026-07-13 | 2026-07-09 | CURRENT REPORT | 0001213900-26-077296 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-08 | — | SCHEDULE 13G Filing | 0000929638-26-002570 | View SEC Doc Filr Page |
| ARS | 2026-06-30 | 2025-12-31 | FORM ARS | 0001213900-26-073369 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-30 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-073368 | View SEC Doc Filr Page |
| DEF 14A | 2026-06-30 | 2026-08-14 | DEFINITIVE PROXY STATEMENT | 0001213900-26-073367 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-17 | CURRENT REPORT | 0001213900-26-070212 | View SEC Doc Filr Page |
| PRE 14A | 2026-06-18 | 2026-08-14 | DEFINITIVE PROXY STATEMENT | 0001213900-26-070208 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-06-01 | CURRENT REPORT | 0001213900-26-064804 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-06-01 | CURRENT REPORT | 0001213900-26-063185 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-056079 | View SEC Doc Filr Page |
| 424B3 | 2026-04-16 | — | PROSPECTUS | 0001213900-26-044649 | View SEC Doc Filr Page |
| EFFECT | 2026-04-15 | — | EFFECT Filing | 9999999995-26-001189 | View SEC Doc Filr Page |
| 424B3 | 2026-04-14 | — | PROSPECTUS | 0001213900-26-043614 | View SEC Doc Filr Page |
| POS AM | 2026-04-14 | — | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 | 0001213900-26-043571 | View SEC Doc Filr Page |